Clinical trial · Observational
Multi-center Application of Quantitative FIT Technology in Colorectal Cancer Screening
Multi-center Application Study of Quantitative FIT Technology for Colorectal Cancer Screening in Chinese Physical Examination Population
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In order to control the incidence of colorectal cancer, improve the level of early diagnosis and early warning the occurrence of colorectal cancer, it is very necessary for us to explore the threshold value of FIT positive judgment in line with the Chinese population, and further contribute to the establishment of a colorectal cancer screening pathway suitable for Chinese healthy population
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer Screening Fecal Immunochemical Test | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Quantitative Fecal Immunochemical Test (qFIT) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Sensitivity of quantitative FIT
- timeFrame
- 1year
- description
- The sensitivity of quantitative FIT application in Chinese physical examination population
- measure
- Specificity of quantitative FIT
- timeFrame
- 1year
- description
- The specificity of quantitative FIT application in Chinese physical examination population
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
Show eligibility criteria text
Inclusion Criteria: 1. Healthy people aged 30 years and planning to undergo colonoscopy; 2. No history of gastrointestinal tumor; 3. No ulcerative colitis or Crohn's disease; 4. No gastrointestinal hemorrhagic disease; 5. No history of gastrointestinal surgery, able to understand and willing to sign informed consent. Exclusion Criteria: 1. Other serious diseases of the digestive tract, such as Crohn's disease ulcerative colitis; 2. Patients with gastric and esophageal cancer and other malignant tumors; 3. Unable to cooperate after communication; 4. Subjects who have received radiotherapy and chemotherapy; 5. Other researchers believe that they are not suitable for inclusion in this clinical trial, such as mental illness patients, critical patients, pregnant women, illiterate minors, cognitive impairment PI, students of the researcher, PI, affiliated research units of the co-investigator or employees of the sponsor, etc
References
Publications (0)
Data not yet available